Exabis Library
Welcome to the e-CCO Library!
P287: Differentiating neoplasic and non-neoplasic raised lesions (polyps and pseudopolyps) in long-standing ulcerative colitis: results from a prospective systematic study using virtual chromoendoscopy with i-SCAN and the Kudo classification
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P287: Lipid peroxidation levels and antioxidant status in serum, plasma and saliva of patients with active and inactive Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P287: The clinical utility of low radiation dose computed tomography as a first-line investigation for evaluation of small bowel pathology
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P288 Gut barrier failure biomarkers in IBD: Is there anything new beyond „The Wall’?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P288: A real-world study of outcomes in biologic-naïve patients with Crohn’s disease and ulcerative colitis initiating vedolizumab
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P288: Application of a new classification of Fistulizing Perianal Crohn's Disease (FPCD) in clinical practice: evaluating the correlation between clinician and patient's assessments and FPCD patient´s quality of life
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P288: Is there any value of preoperative small bowel evaluation in patients with ulcerative colitis about to undergo ileal pouch-anal anastomosis?
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P288: Pregnancy and delivery outcomes in patients with ulcerative colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P288: Recurrence rates of advanced neoplasia after endoscopic or surgical resection in Inflammatory Bowel Disease patients: a retrospective cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P288: Treating beyond symptoms in inflammatory bowel disease (IBD): the Kent IBD Nurse Experience with the Steroid assessment tool
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P288: Vedolizumab May Be An Effective Option For The Management Of Postoperative Recurrence Of Crohn’s Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P289 Biological therapies and the trajectories of biopsychological factors in inflammatory bowel diseases
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P289: A French nationwide prospective study on patients with Crohn’s disease and ulcerative colitis treated with Infliximab-biosimilar CT-P13 in a real-life setting: two-year follow-up of the ReFLECT study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P289: Cytomegalovirus reactivation in ulcerative colitis is related to severe inflammatory activity
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P289: Evaluation of the safety and effectiveness of direct-acting antiviral drugs in the treatment of hepatitis C in patients with inflammatory bowel disease: National multicenter study (ENEIDA registry). MIC project.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P289: Hyperoxaluria in patients after ileocolic resection
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P289: Outcome of endoscopic ally resected dysplasic lesions in ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P289: The initial development of a Chat-Bot for inflammatory bowel disease (IBD) patients for use in e-health applications
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P289: Transcutaneous nonlinearity strain ultrasound differentiates early vs. advanced fibrotic intestine in vivo in the TNBS rat model and is feasible in patients with Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM